|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Current assets | ||||||||||||||
| Cash | ||||||||||||||
| GST receivables | ||||||||||||||
| Royalty receivables | ||||||||||||||
| Prepaid expenses | ||||||||||||||
| Total current assets | ||||||||||||||
| Reclamation deposits | ||||||||||||||
| Total assets | ||||||||||||||
| Current liabilities | ||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||
| Accounts payable and accrued liabilities - related party | ||||||||||||||
| Notes payable | ||||||||||||||
| Derivative liabilities | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Deferred revenue - royalty agreement (Note 8) | ||||||||||||||
| Asset retirement obligation | ||||||||||||||
| Total long-term liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| Stockholders' equity (deficit) | ||||||||||||||
| Preferred stock: no par value, unlimited shares authorized and none issued | ||||||||||||||
| Common stock: no par value, unlimited shares authorized; 20,085,119 shares issued and outstanding at December 31, 2025 and 2024, respectively | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Common shares to be issued | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||
| Total liabilities and stockholders' equity (deficit) | ||||||||||||||
Loading...